reMYND NV Employee Directory

Biotechnology ResearchFlanders, Belgium11-50 Employees

Remynd is a clinical-stage biotechnology company dedicated to developing first-in-class oral therapeutics for neurodegenerative diseases, including Alzheimer’s disease and Huntington’s disease. By targeting the underlying disease mechanisms, reMYND aims to restore neuronal function and slow disease progression. With a strong commitment to innovation and patient impact, the company advances breakthrough therapies from discovery to clinical development.

Find reMYND NV employees' phone numbers or email addresses

reMYND NV Global Highlights

Location
Employees

Europe
37

Minus sign iconPlus sign icon
  • Belgium
    32
  • Spain
    2
  • France
    2
  • Poland
    1

Oceania
1

Minus sign iconPlus sign icon
  • Australia
    1

reMYND NV's Leadership

  • Stylized image of a person
    F. S.
    Chief Executive Officer
    Phone icon
  • Stylized image of a person
    D. T.
    Cro Study Director
    Phone icon
  • Stylized image of a person
    A. S.
    Cro Study Director
    Phone icon
  • Stylized image of a person
    G. G.
    Chief Scientific Officer
    Phone icon
  • Stylized image of a person
    K. P.
    Head Of Operations
    Phone icon
  • Stylized image of a person
    S. G.
    Co-Founder
    Phone icon
  • Stylized image of a person
    K. A.
    Hr Manager
    Phone icon
  • Stylized image of a person
    P. L.
    Project Manager
    Phone icon

reMYND NV Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Entrepreneurship
  • Business
  • Administrative
  • Pharmaceuticals
  • Other
  • Program & Project Management
  • Sales
  • Engineering

Contact profiles from reMYND NV

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    S. D.
    Senior Lab Technician
    Phone icon
    BelgiumFlemish Region
    Jan 05, 2025
  • Stylized image of a person
    K. D. W.
    Shareholder And Investor
    Phone icon
    BelgiumBrussels Capital
    Feb 05, 2026
  • Stylized image of a person
    J. P.
    Scientist
    Phone icon
    Belgium
    Feb 05, 2026
  • Stylized image of a person
    K. C.
    Expert Research Associate
    Phone icon
    Mar 24, 2026
  • Stylized image of a person
    I. V.
    Stagiair
    Phone icon
    Belgium
    Apr 16, 2026
  • Stylized image of a person
    E. C.
    Technician
    Phone icon
    Belgium
    Feb 04, 2024
  • Stylized image of a person
    L. P.
    Cns In Vivo Pharmacology Manager
    Phone icon
    Belgium
    Aug 26, 2024
  • Stylized image of a person
    E. D.
    Project Manager Drug Discovery Unit
    Phone icon
    Belgium
    Feb 16, 2026

Frequently Asked Questions

What is reMYND NV known for?

Minus sign iconPlus sign icon
reMYND NV was founded in 2002 operates in the Biotechnology Research industry. The company's main headquarters is located in 1 Gaston Geenslaan Heverlee, Flanders Belgium; you can contact the main corporate office by phone at . Explore reMYND NV's company overview page for more information.

What is reMYND NV's most common email format?

Minus sign iconPlus sign icon
reMYND NV employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more reMYND NV email formats with LeadIQ.

How many employees does reMYND NV have currently?

Minus sign iconPlus sign icon
reMYND NV has approximately 30 employees as of April 2026. These team members are located across 2 continents, including EuropeOceania.

Who are reMYND NV's key employees and leadership?

Minus sign iconPlus sign icon

As of April 2026, reMYND NV's key employees include:

  • Chief Executive Officer: F. S.
  • Cro Study Director: D. T.
  • Cro Study Director: A. S.
  • Chief Scientific Officer: G. G.
  • Head Of Operations: K. P.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.